| Product NDC: | 24623-001 |
| Proprietary Name: | Advanced Protection |
| Non Proprietary Name: | OCTINOXATE and Zinc Oxide |
| Active Ingredient(s): | .075; .05 g/g; g/g & nbsp; OCTINOXATE and Zinc Oxide |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 24623-001 |
| Labeler Name: | CBI Laboratories, Inc |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20010825 |
| Package NDC: | 24623-001-20 |
| Package Description: | 56.7 g in 1 TUBE (24623-001-20) |
| NDC Code | 24623-001-20 |
| Proprietary Name | Advanced Protection |
| Package Description | 56.7 g in 1 TUBE (24623-001-20) |
| Product NDC | 24623-001 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | OCTINOXATE and Zinc Oxide |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20010825 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | CBI Laboratories, Inc |
| Substance Name | OCTINOXATE; ZINC OXIDE |
| Strength Number | .075; .05 |
| Strength Unit | g/g; g/g |
| Pharmaceutical Classes |